| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/12/2007 | WO2007039436A1 Treatment of neurodegenerative disorders |
| 04/12/2007 | WO2007039389A1 Isoxazolo derivatives as gaba a alpha5 inverse agonists |
| 04/12/2007 | WO2007039285A1 Bicyclic aromatic compounds useful as inhibitors of mitogen-activated protein kinase-activated protein kinase-2 |
| 04/12/2007 | WO2007039264A1 Pyrazolo [1, 5 -alpha] pyrimidinyl derivatives useful as corticotropin-releasing factor (crf) receptor antagonists |
| 04/12/2007 | WO2007039220A1 Novel quinoline compounds capable of binding at the cb2 receptor |
| 04/12/2007 | WO2007039219A1 Quinoline compounds capable of binding the cb2 and/or the 5-ht6 receptor |
| 04/12/2007 | WO2007039175A1 N-[1 ,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals |
| 04/12/2007 | WO2007039173A1 Cyclic n-[1 ,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals |
| 04/12/2007 | WO2007039171A1 4-oxy-n-[1 ,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals |
| 04/12/2007 | WO2007039138A1 Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment |
| 04/12/2007 | WO2007038874A1 Grape seed extract and its constituents for use as cyp2a6 inhibitors |
| 04/12/2007 | WO2007022415A3 Substituted 2-aminothiazoles for treating neurodegenerative diseases |
| 04/12/2007 | WO2007022305A3 2-aminoimidazopyridines for treating neurodegenerative diseases |
| 04/12/2007 | WO2007020213A3 Thiazolyl piperidine derivatives useful as h3 receptor modulators |
| 04/12/2007 | WO2007016209A3 Pure 1,2-benzisoxazole-3-methane-sulfonic acid sodium salt and purification process |
| 04/12/2007 | WO2007015175A3 Use of pp-1 inhibitors to prevent missplicing events |
| 04/12/2007 | WO2007015002A3 Novel crystalline iv form of agomelatine, method of the preparation thereof and pharmaceutical compositions containing said form |
| 04/12/2007 | WO2007010138A3 N(arylalkyl)-1h-pyrrolopyridine-2-carboxamide derivatives, preparation and therapeutic use thereof |
| 04/12/2007 | WO2007009720A3 Prodrugs of pyrazoline compounds, their preparation and use as medicaments |
| 04/12/2007 | WO2007003421A3 Humanised antibodies specific for nogo-a and pharmaceutical uses thereof |
| 04/12/2007 | WO2007002214A3 Acyl guanidines as beta-secretase inhibitors |
| 04/12/2007 | WO2006138230A3 The preparation and use of protease inhibitors |
| 04/12/2007 | WO2006136580A3 2-(phenylamino)benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels |
| 04/12/2007 | WO2006116221A3 Therapeutic combinations for the treatment or prevention of psychotic disorders |
| 04/12/2007 | WO2006100595A3 Chewing gum compositions of varenicline |
| 04/12/2007 | WO2006084894A3 Use of tryptophan in combination with caffeine and taurine, foodstuff and beverage containing said combination |
| 04/12/2007 | WO2006073726A3 Use of certain biphenyl compounds for protection of neurons and oligodendrocytes in the treatment of multiple sclerosis (ms) |
| 04/12/2007 | WO2006040534A3 Method of detecting the presence or activity of g - protein coupled receptor 92 (gpr92) |
| 04/12/2007 | WO2002086079A3 T1r3 a novel taste receptor |
| 04/12/2007 | US20070082957 2-chloro-5-(3-oxopropyl)-N-(tricyclo[3.3.1.13,7]dec-1-ylmethyl)-benzamide; P2X7 receptor antagonists; inflammatory, immune or cardiovascular diseases |
| 04/12/2007 | US20070082954 Pharmaceutical compositions containing (+) cannabidioil and derivatives thereof and some such novel derivatives |
| 04/12/2007 | US20070082938 Polymorphs of bicifadine hydrochloride |
| 04/12/2007 | US20070082927 Piperidine derivative having nmda receptor antagonistic activity |
| 04/12/2007 | US20070082912 Pyrrole compounds for the treatment of prostaglandine mediated diseases |
| 04/12/2007 | US20070082899 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| 04/12/2007 | US20070082897 Acylated indanyl amines and their use as pharmaceuticals |
| 04/12/2007 | US20070082846 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 04/12/2007 | US20070082341 Human phospholipases |
| 04/12/2007 | US20070082041 Topical delivery of codrugs |
| 04/12/2007 | US20070082037 Transdermal preparations and method for relieving side effects in pergolide therapy |
| 04/12/2007 | DE112005000737T5 Mit Heparansulfat-Zuckerketten modifizierte Heparin-bindende Proteine, Verfahren zur Erzeugung derselben und Arzneimittel, welche dieselben enthalten With heparan sulfate sugar chains modified heparin-binding proteins, methods for producing the same and pharmaceutical compositions containing the same |
| 04/12/2007 | CA2624882A1 Pyrazolopyrimidines as protein kinase inhibitors |
| 04/12/2007 | CA2624875A1 New pyrimidine derivatives and their use in therapy as well as the use of pyrimidine derivatives in the manufacture of a medicament for prevention and/or treatment of alzheimer's disease |
| 04/12/2007 | CA2624869A1 New compounds ii |
| 04/12/2007 | CA2624795A1 Use of fused pyrrole carboxylic acids for the treatment of neurodegenerative and psychiatric diseases as d-amino acid oxidase inhibitors |
| 04/12/2007 | CA2624731A1 Hydrogenated pyrido-indole compounds for the treatment of huntington's disease |
| 04/12/2007 | CA2624726A1 4-oxy-n-[1 ,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals |
| 04/12/2007 | CA2624699A1 Pyrazolo [1,5-alpha] pyrimidinyl derivatives useful as corticotropin-releasing factor (crf) receptor antagonists |
| 04/12/2007 | CA2624681A1 N-[1 ,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals |
| 04/12/2007 | CA2624649A1 Novel imidazo [4,5 -b] pyridine derivatives as inhibitors of glycogen synthase kinase 3 for use in the treatment of dementia and neurodegenerative disorders |
| 04/12/2007 | CA2624562A1 Binding domains of proteins of the repulsive guidance molecule (rgm) protein family and functional fragments thereof, and their use |
| 04/12/2007 | CA2624495A1 Preparation and use of tetrahydropyrrolo [3, 2-c] pyridin-4-one derivatives for treatment of obesity, psychiatric and neurological disorders |
| 04/12/2007 | CA2624468A1 Bicyclic aromatic compounds useful as inhibitors of mitogen-activated protein kinase-activated protein kinase-2 |
| 04/12/2007 | CA2624449A1 Use of neboglamine in the treatment of toxicodependency |
| 04/12/2007 | CA2624413A1 Naphthyridin derivatives |
| 04/12/2007 | CA2624326A1 Cyclic n-[1 ,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals |
| 04/12/2007 | CA2624220A1 1- (1h- indol- 1-yl) -3- (methylamino) -1- phenylpropan-2-ol derivatives and related compounds as modulators of the monoamine reuptake for the treatment of vasomotor symptoms (vms) |
| 04/12/2007 | CA2624141A1 Quinazoline derivative and pharmaceutical |
| 04/12/2007 | CA2623721A1 Oxadiazolyl pyrazolo-pyrimidines as mglur2 antagonists |
| 04/12/2007 | CA2623715A1 Indol-3-yl-carbonyl-azaspiro derivatives as vasopressin receptor antagonists |
| 04/12/2007 | CA2623450A1 Methods and compositions for improving cognitive function |
| 04/12/2007 | CA2623423A1 Substituted propylamine derivatives and methods of their use |
| 04/12/2007 | CA2623359A1 9-azabicyclo [3.3.1] nonane derivatives as monoamine reuptake inhibitors |
| 04/12/2007 | CA2623114A1 Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment |
| 04/12/2007 | CA2623043A1 Isoxazolo derivatives as gaba a alpha5 inverse agonists |
| 04/12/2007 | CA2623009A1 5- (phenylisoxazolylethoxy) -triazol- 3 -yl substituted pyridine compounds for the treatment of neurological, psychiatric or pain disorders |
| 04/12/2007 | CA2622609A1 The use of an erythropoietin moiety to treat neurodegenerative disorders |
| 04/12/2007 | CA2621326A1 Conserved membrane activator of calcineurin (cmac), a novel therapeutic protein and target |
| 04/12/2007 | CA2575827A1 Antiepileptogenic complex of albumin with docosahexaenoate |
| 04/11/2007 | EP1772514A2 Manipulation of tissue or organ type using the notch pathway |
| 04/11/2007 | EP1772464A2 Methods of identifying indirect agonists of IGF-1 |
| 04/11/2007 | EP1772454A1 Nitrogenous fused bicyclic compound |
| 04/11/2007 | EP1772149A1 Drug for prevention or treatment of diabetes |
| 04/11/2007 | EP1772146A1 Polyunsaturated fatty acids as bace inhibitors |
| 04/11/2007 | EP1771470A2 Actrii receptor polypeptides, methods and compositions |
| 04/11/2007 | EP1771445A1 Dimeric compounds of piperidine, piperazine or morpholine or their 7-membered analogs suitabale for the treatment of neurodegenerative disorders |
| 04/11/2007 | EP1771436A1 Kynurenic acid amide derivatives as nr2b receptor antagonists |
| 04/11/2007 | EP1771435A2 Modulators of central nervous system neurotransmitters |
| 04/11/2007 | EP1771432A2 Non-imidazole heterocyclic compounds as histamine h3 receptor modulators |
| 04/11/2007 | EP1771429A1 New benzoyl urea derivatives |
| 04/11/2007 | EP1771422A1 Quinazolinone derivatives as parp inhibitors |
| 04/11/2007 | EP1771417A1 Substituted 3-phenylpiperidine derivatives |
| 04/11/2007 | EP1771416A1 A novel polymorph of (1-benzyl-4-[(5,6-dimethoxy-1-indanone)-2-yl] methyl piperidine hydrochloride (donepezil hydrochloride) and a process for producing thereof |
| 04/11/2007 | EP1771415A1 2- (1h-indolylsulfanyl) -aryl amine derivatives for use in the treatment of affective disorders, pain, adhd and stress urinary incontinence |
| 04/11/2007 | EP1771208A2 Use of thioflavin radiolabeled derivatives in amyloid imaging for assessing anti-amyloid therapies |
| 04/11/2007 | EP1771178A1 Use of k-252a and kinase inhibitors for the prevention or treatment of hmgb1-associated pathologies |
| 04/11/2007 | EP1696930B1 Tricyclic 1-((3-indol-3-yl)carbonyl)piperazine derivatives as cannabinoid cb1 receptor agonists |
| 04/11/2007 | EP1689385B1 Neuroactive substance and uses of one such substance |
| 04/11/2007 | EP1682503B1 Derivatives of n-[phenyl(alkylpiperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics |
| 04/11/2007 | EP1641756B1 4-arylsulphonylpiperidine derivatives for antagonism of the 5-ht2a receptor |
| 04/11/2007 | EP1567496B1 Phenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain or gastrointestinal disorders |
| 04/11/2007 | EP1511759A4 Modulators and inhibitors of fibroblast growth factor receptor 5-polypeptides and gene expression thereof. |
| 04/11/2007 | EP1480972B1 Compounds possessing affinity at 5ht1-type receptors and use thereof in therapy of cns disorders |
| 04/11/2007 | EP1458689B1 Aryloxyphenyl and arylsulfanylphenyl derivatives |
| 04/11/2007 | EP1435985B1 Medicament containing activated antithrombin iii |
| 04/11/2007 | EP1414458B1 Oral administration of 6-hydroxy-oxymorphone for use as an analgesic |
| 04/11/2007 | EP1392641B1 Substituted cyclohexane-1,4-diamine derivatives |
| 04/11/2007 | EP1341767B1 Imidazole and benzimidazole caspase inhibitors and uses thereof |
| 04/11/2007 | EP1272177B1 Method and formulation for treating resistance to antihypertensives and related conditions |
| 04/11/2007 | EP1207868B1 Pharmaceutical tramadol salts |